Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bereson Pharmaceutical is a high-tech biotechnology company based in Jiangyin, China, specializing in the development of regenerative medicine and advanced wound care solutions. Founded by Dr. Gu Ming, the company focuses on the research and industrialization of signal proteins and bioactive materials for tissue repair and skin health. Their product portfolio includes medical-grade wound dressings, sprays, and gels designed to treat chronic wounds, burns, and post-operative recovery. Bereson leverages a proprietary platform to produce recombinant proteins that mimic natural healing factors, positioning itself as a leader in the Chinese regenerative biomaterials market. The company serves both clinical hospital settings and the consumer dermo-cosmetic market through its specialized brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangyin Bereson Pharmaceutical.